AAAAAA
Results: 1-25/44
Authors:
Martinez, A
Walker, RA
Shaw, JA
Dearing, SJ
Maher, ER
Latif, F
Citation: A. Martinez et al., Chromosome 3p allele loss in early invasive breast cancer: detailed mapping and association with clinicopathological features, J CL PATH-M, 54(5), 2001, pp. 300-306
Authors:
Alvi, AJ
Rader, JS
Broggini, M
Latif, F
Maher, ER
Citation: Aj. Alvi et al., Microsatellite instability and mutational analysis of transforming growth factor beta receptor type II gene (TGFBR2) in sporadic ovarian cancer, J CL PATH-M, 54(4), 2001, pp. 240-243
Authors:
Clifford, SC
Cockman, ME
Smallwood, AC
Mole, DR
Woodward, ER
Maxwell, PH
Ratcliffe, PJ
Maher, ER
Citation: Sc. Clifford et al., Contrasting effects on HIF-1 alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease, HUM MOL GEN, 10(10), 2001, pp. 1029-1038
Authors:
Astuti, D
Agathanggelou, A
Honorio, S
Dallol, A
Martinsson, T
Kogner, P
Cummins, C
Neumann, HPH
Voutilainen, R
Dahia, P
Eng, C
Maher, ER
Latif, F
Citation: D. Astuti et al., RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours, ONCOGENE, 20(51), 2001, pp. 7573-7577
Authors:
Clifford, SC
Astuti, D
Hooper, L
Maxwell, PH
Ratcliffe, PJ
Maher, ER
Citation: Sc. Clifford et al., The pVHL-associated SCF ubiquitin ligase complex: Molecular genetic analysis of elongin B and C, Rbx1 and HIF-1 alpha in renal cell carcinoma, ONCOGENE, 20(36), 2001, pp. 5067-5074
Methylation associated inactivation of RASSF1A from region 3p21.3 in lung,breast and ovarian tumours
Authors:
Agathanggelou, A
Honorio, S
Macartney, DP
Martinez, A
Dallol, A
Radar, J
Fullwood, P
Chauhan, A
Walker, R
Shaw, JA
Hosoe, S
Lerman, MI
Minna, JD
Maher, ER
Latif, F
Citation: A. Agathanggelou et al., Methylation associated inactivation of RASSF1A from region 3p21.3 in lung,breast and ovarian tumours, ONCOGENE, 20(12), 2001, pp. 1509-1518
Authors:
Schofield, PN
Joyce, JA
Lam, WK
Grandjean, V
Ferguson-Smith, A
Reik, W
Maher, ER
Citation: Pn. Schofield et al., Genomic imprinting and cancer; new paradigms in the genetics of neoplasia, TOX LETT, 120(1-3), 2001, pp. 151-160
Authors:
Smith, WM
Zhou, XP
Kurose, K
Gao, X
Latif, F
Kroll, T
Sugano, K
Cannistra, SA
Clinton, SK
Maher, ER
Prior, TW
Eng, C
Citation: Wm. Smith et al., Opposite association of two PPARG variants with cancer: overrepresentationof H449H in endometrial carcinoma cases and underrepresentation of P12A inrenal cell carcinoma cases, HUM GENET, 109(2), 2001, pp. 146-151
Authors:
Astuti, D
Douglas, F
Lennard, TWJ
Aligianis, IA
Woodward, ER
Evans, DGR
Eng, C
Latif, F
Maher, ER
Citation: D. Astuti et al., Germline SDHD mutation in familial phaeochromocytoma, LANCET, 357(9263), 2001, pp. 1181-1182
Authors:
Clifford, SC
Maher, ER
Citation: Sc. Clifford et Er. Maher, von Hippel-Lindau disease: Clinical and molecular perspectives, ADV CANC R, 82, 2001, pp. 85-105
Authors:
Morrissey, C
Martinez, A
Zatyka, M
Agathanggelou, A
Honorio, S
Astuti, D
Morgan, NV
Moch, H
Richards, FM
Kishida, T
Yao, M
Schraml, P
Latif, F
Maher, ER
Citation: C. Morrissey et al., Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma, CANCER RES, 61(19), 2001, pp. 7277-7281
Authors:
Wiesener, MS
Munchenhagen, PM
Berger, I
Morgan, NV
Roigas, J
Schwiertz, A
Jurgensen, JS
Gruber, G
Maxwell, PH
Loning, SA
Frei, U
Maher, ER
Grone, HJ
Eckardt, KU
Citation: Ms. Wiesener et al., Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1 alpha in clear cell renal carcinomas, CANCER RES, 61(13), 2001, pp. 5215-5222
Authors:
Parry, L
Maynard, JH
Patel, A
Clifford, SC
Morrissey, C
Maher, ER
Cheadle, JP
Sampson, JR
Citation: L. Parry et al., Analysis of the TSC1 and TSC2 genes in sporadic renal cell carcinomas, BR J CANC, 85(8), 2001, pp. 1226-1230
Authors:
Kurose, K
Zhou, XP
Araki, T
Cannistra, SA
Maher, ER
Eng, C
Citation: K. Kurose et al., Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas, AM J PATH, 158(6), 2001, pp. 2097-2106
Authors:
Astuti, D
Latif, F
Dallol, A
Dahia, PLM
Douglas, F
George, E
Skoldberg, F
Husebye, ES
Eng, C
Maher, ER
Citation: D. Astuti et al., Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma, AM J HU GEN, 69(1), 2001, pp. 49-54
Authors:
Martinez, A
Fullwood, P
Kondo, K
Kishida, T
Yao, M
Maher, ER
Latif, F
Citation: A. Martinez et al., Role of chromosome 3p12-p21 tumour suppressor genes in clear cell renal cell carcinoma: analysis of VHL dependent and VHL independent pathways of tumorigenesis, J CL PATH-M, 53(3), 2000, pp. 137-144
Authors:
Beales, PL
Reid, HAS
Griffiths, MH
Maher, ER
Flinter, FA
Woolf, AS
Citation: Pl. Beales et al., Renal cancer and malformations in relatives of patients with Bardet-Biedl syndrome, NEPH DIAL T, 15(12), 2000, pp. 1977-1985
Authors:
Woodward, ER
Buchberger, A
Clifford, SC
Hurst, LD
Affara, NA
Maher, ER
Citation: Er. Woodward et al., Comparative sequence analysis of the VHL tumor suppressor gene, GENOMICS, 65(3), 2000, pp. 253-265
Authors:
Libutti, SK
Choyke, PL
Alexander, HR
Glenn, G
Bartlett, DL
Zbar, B
Lubensky, I
McKee, SA
Maher, ER
Linehan, WM
Walther, MM
Citation: Sk. Libutti et al., Clinical and genetic analysis of patients with pancreatic neuroendocrine tumors associated with von Hippel-Lindau disease, SURGERY, 128(6), 2000, pp. 1022-1027
Authors:
Desai, DC
Lockman, JC
Chadwick, RB
Gao, X
Percesepe, A
Evans, DGR
Miyaki, M
Yuen, ST
Radice, P
Maher, ER
Wright, FA
de la Chapelle, A
Citation: Dc. Desai et al., Recurrent germline mutation in MSH2 arises frequently de novo, J MED GENET, 37(9), 2000, pp. 646-652
Authors:
Green, EK
Priestley, MD
Waters, J
Maliszewska, C
Latif, F
Maher, ER
Citation: Ek. Green et al., Detailed mapping of a congenital heart disease gene in chromosome 3p25, J MED GENET, 37(8), 2000, pp. 581-587
Authors:
Woodward, ER
Clifford, SC
Astuti, D
Affara, NA
Maher, ER
Citation: Er. Woodward et al., Familial clear cell renal cell carcinoma (FCRC): clinical features and mutation analysis of the VHL, MET, and CUL2 candidate genes, J MED GENET, 37(5), 2000, pp. 348-353
Authors:
Catchpoole, D
Smallwood, AV
Joyce, JA
Murrell, A
Lam, W
Tang, T
Munroe, D
Reik, W
Schofield, PN
Maher, ER
Citation: D. Catchpoole et al., Mutation analysis of H19 and NAP1L4 (hNAP2) candidate genes and IGF2 DMR2 in Beckwith-Wiedemann syndrome, J MED GENET, 37(3), 2000, pp. 212-215
Authors:
Engel, JR
Smallwood, A
Harper, A
Higgins, MJ
Oshimura, M
Reik, O
Schofield, PN
Maher, ER
Citation: Jr. Engel et al., Epigenotype-phenotype correlations in Beckwith-Wiedemann syndrome, J MED GENET, 37(12), 2000, pp. 921-926
Authors:
Hes, FJ
McKee, S
Taphoorn, MJB
Rehal, P
van der Luijt, RB
McMahon, R
van der Smagt, JJ
Dow, D
Zewald, RA
Whittaker, J
Lips, CJM
MacDonald, F
Pearson, PL
Maher, ER
Citation: Fj. Hes et al., Cryptic von Hippel-Lindau disease: germline mutations in patients with haemangioblastoma only, J MED GENET, 37(12), 2000, pp. 939-943